Patients who were sedated and intubated during the first wave of COVID-19 recovered and improved—with time and supportive care.
Retail prescription prices drove the costs of drugs for multiple sclerosis to a high of approximmately $85.4 billion in the US.
Greater awareness of sleep disorders has prompted more people to seek treatment. What's changed in 20 years?
See More Videos